Zobrazeno 1 - 10
of 63
pro vyhledávání: '"F R, Rickles"'
Autor:
M. Di Nisio, Pieter Willem Kamphuisen, A. Van de Geer, Harry R. Büller, Charles Faselis, Anita Aggarwal, F. R. Rickles, A. Kleinjan
Publikováno v:
Thrombosis and Haemostasis, 110(5), 959-965. GEORG THIEME VERLAG KG
Thrombosis and haemostasis, 110(5), 959-965. Schattauer GmbH
Thrombosis and haemostasis, 110(5), 959-965. Schattauer GmbH
SummaryLow-molecular-weight heparin (LWMH) is recommended as the preferred anticoagulant treatment over vitamin K antagonists (VKA) for venous thromboembolism (VTE) in patients with cancer. However, there is uncertainty about the duration and dose of
Autor:
F. R. Rickles
Publikováno v:
Journal of Thrombosis and Haemostasis. 4:557-559
Publikováno v:
Blood Coagulation & Fibrinolysis. 3:429-437
Blood coagulation test results were collected prospectively in patients with previously untreated, advanced lung or colon cancer who entered into a clinical trial. In patients with colon cancer, reduced survival was associated (in univariate analysis
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 6(1)
We report our experience with the incidence of adverse events during the use of Stimate brand intranasal desmopressin acetate (IN DDAVP) for patients with haemophilia A (HA) or von Willebrand disease (vWD) after noting two severe adverse events in on
Publikováno v:
Circulation. 96(2)
For the present study, we hypothesized that fibrin is an inducer of tissue factor (TF) expression in vascular endothelial cells in vitro and in vivo.To test the in vitro aspect of this hypothesis, human umbilical vein endothelial cells (HUVECs) were
Autor:
C K, Kasper, D L, Aronson, G, Davignon, P, Foster, C, Hillman-Wiseman, J M, Lusher, M, Manco-Johnson, J B, Meade, R R, Montgomery, F R, Rickles
Publikováno v:
Thrombosis and haemostasis. 74(3)
Six brands of normal reference plasma produced in the United States, with assigned assay values for factor VII and IX and, in four instances, ristocetin cofactor and van Willebrand antigen, were assayed in nine coagulation laboratories in academic in
Publikováno v:
Thrombosis and haemostasis. 74(1)
Tissue factor (TF) exists in a cryptic form [i.e. without procoagulant activity (PCA)] in peripheral blood monocytes and quiescent tissue macrophages but is expressed constitutively in most human tumor cells. Induction and cell surface expression of
Publikováno v:
Blood purification. 13(5)
Thrombotic thrombocytopenic purpura (TTP) is a rare syndrome which presents typically with thrombocytopenia, microangiopathic hemolytic anemia, central nervous system symptoms, fever, and renal abnormalities. The diagnosis of TTP in pregnancy previou
Autor:
A. van der Geer, A. Kleinjan, Pieter Willem Kamphuisen, Charles Faselis, F. R. Rickles, Harry R. Büller, A. Aggerwal
Publikováno v:
Thrombosis Research, 129. PERGAMON-ELSEVIER SCIENCE LTD
Introduction: Since the results of the CLOT trial were published in 2003, low-molecular-weight heparin (LWMH) has been recommended as the preferred anticoagulant treatment over vitamin K antagonists (VKAs) for venous thromboembolism (VTE) in patients
Publikováno v:
The American journal of pathology. 145(6)
Tissue factor (TF), the primary initiator of blood coagulation in vivo, is expressed in vitro by a variety of cells. Previous efforts to localize TF in tissue and cells have been limited principally to the use of immunological techniques. In the pres